Skip to main content

Site notifications

TICALOR; BLOOMS THE CHEMIST TICAGRELOR; APO-TICAGRELOR; TICAGRELOR ARX (Accelagen Pty Ltd)

Product name
TICALOR; BLOOMS THE CHEMIST TICAGRELOR; APO-TICAGRELOR; TICAGRELOR ARX
Date registered
Evaluation commenced
Decision date
Approval time
145 (255 working days)
Active ingredients
Ticagrelor
Registration type
New generic medicine
Indication

TICALOR; BLOOMS THE CHEMIST TICAGRELOR; APO-TICAGRELOR; TICAGRELOR ARX (tablet), in combination with aspirin, is indicated for the prevention of atherothrombotic events (cardiovascular death, myocardial infarction and stroke) in adult patients with acute coronary syndromes (unstable angina [UA], non ST elevation Myocardial Infarction [NSTEMI] or ST elevation Myocardial Infarction [STEMI]) including patients managed medically, and those who are managed with percutaneous coronary intervention (PCI) or coronary artery by-pass grafting (CABG).

Help us improve the Therapeutic Goods Administration site